The largest database of trusted experimental protocols

25 protocols using t0070907

1

Human Aortic Smooth Muscle Cell Manipulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human aortic smooth muscle cells (HASMCs) from ScienCell Research Laboratories were isolated from human aorta and cultured in smooth muscle cell medium (SMCM, Cat. #1101, ScienCell, USA) supplemented with 2% FBS, 1% SMCGS, and 1% penicillin and streptomycin. Experiments were performed using cells from passages 3–6. For reproducibility, we purchased and applied two batches of HASMCs in the following experiments. HEK293T cells were purchased from China Center for Type Culture Collection (Wuhan University, Hubei, China). Cells were cultured in DMEM supplemented with 10% fetal bovine serum, 100 U/ml penicillin, and 100 g/ml streptomycin and maintained at 37 °C in 5% CO2. The duplex siRNA targeting NLRC5 (SASI_Hs02_00359503) and scramble siRNA (siCtr) were purchased from Sigma incorporation (Sigma, USA). The siRNA-targeting PPARγ was purchased from Sangon Biotech (Shanghai, China) and the sequences are as followed: sense- 5′-CUG GCC UCC UUG AUG AAU ATT-3′, antisense-5′-UAU UCA UCA AGG AGG CCA GTT-3′. HASMCs, seeded in a six-well plate at the density of 1.5 × 106 cells/well, were transfected with 50 nM siRNA using 3 μl of RNAiMAX (Thermo Fisher, USA) in OPTI-MEM (Thermo Fisher, USA) for 24 h. Pioglitazone (CDS021593, Sigma), a therapeutic drug for diabetes, was used as an agonist of PPARγ. T0070907 (S2871, Selleck Chemicals, USA) was used as an antagonist of PPARγ.
+ Open protocol
+ Expand
2

Macrophage Polarization Modulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fluvastatin capsules were purchased from Novartis Pharmaceutical Co., Ltd. (Beijing, China). A Masson staining kit was purchased from Leagene Biotechnology Co., Ltd. (Beijing, China). A hematoxylin-eosin staining kit was purchased from Servicebio Technology Co., Ltd. (Wuhan, China). Cell Counting Kit-8 (CCK-8) was obtained from Fcmacs Biotech Co., Ltd. (Nanjing, China). A BCA protein assay kit was purchased from Beyotime Biotechnology Co., Ltd. (Shanghai, China). Rosiglitazone (RSG, selective PPAR-γ agonist) and T0070907 (selective PPAR-γ antagonist) were obtained from Selleck Chemicals (Houston, USA). LPS was purchased from Sigma Chemical (St. Louis, USA). Recombinant rat IL-4 and INF-γ were purchased from PeproTech Inc. (New Jersey, USA). ELISA kits (IL-1, IL-6, TNF-α, IL4, IL-10, IL-13, and TGF-β1) were obtained from JinYiBai Biological Technology (Nanjing, China). The antibodies (JAK2, STAT6, and p-STAT1) were purchased from Santa Cruz Biotechnology (California, USA). The antibodies (PPAR-γ, STAT1, and p-PPAR-γ) were purchased from Bioss (Beijing, China). The antibodies (SOCS1, SOCS3, p-JAK2, and p-STAT6) were purchased from Affinity Biosciences. APC-anti-mouse CD86 was purchased from BioLegend (San Diego, USA). PE-Cy7-anti-mouse CD206 and Intracellular Fixation & Permeabilization set were purchased from Thermo Fisher Scientific (Massachusetts, USA).
+ Open protocol
+ Expand
3

Sorafenib and T0070907 Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
PMS was purchased from Shifeng Biological Technology Co., Ltd., and dissolved in a solution of ethanol and double distilled water at a ratio of 1:1. Sorafenib (10 mM) was purchased from Selleck Chemicals to be used as positive control and was digested in a solution containing DMSO (63 mg/ml, warmed to 25˚C). T0070907 was purchased from Selleck Chemicals. It has been previously reported that T0070907 is a selective ligand for PPARγ, functioning as an antagonist (18 (link)).
+ Open protocol
+ Expand
4

Exploring PPARγ Modulation in Pancreatic Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human pancreatic cancer cell lines PANC-1, HPAC, AsPC-1, SW1990, MIAPaCa-2, Capan-1 were gifted from department of surgery, Klinikum rechts der Isar, Technical University of Munich. All cell lines used in this study are considered to be identical to the reference cell line in the Cell Bank STR database. Mycoplasma testing is also negative.
All cell lines were cultured in a suggested medium according to ATCC protocols in a humidified incubator at 37°C with 5% CO2. HPAC cells with high ALDH1A3 expression and PANC-1 cells with low ALDH1A3 expression were selected for further study.
Rosiglitazone (APExBIO, #A4303), a therapeutic drug for diabetes, was used as an agonist of PPARγ. T0070907(Selleck Chemicals, #S2871) was used as an antagonist of PPARγ. Cells were treated with rosiglitazone (10 and 20 μM) and T0070907 (5 and 10 μM) for 72 h, and then managed for next research steps.
+ Open protocol
+ Expand
5

PPAR-γ Modulation in Sepsis Outcomes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Twenty-four rats were randomized into the following four groups: the sham group (n = 6), the CLP group (n = 6), the PPAR-γ agonist Rosiglitazone-treated group (CLP + ROT group, n = 6), and the PPAR-γ-selective inhibitor T0070907 group (CLP + T007 group, n = 6). Rosiglitazone (10 mg/kg, i.p., Sigma-Aldrich, CA, USA) or T0070907 (1.5 mg/kg, i.p., Selleck Chemicals, Houston, TX, USA) or sterile normal saline was administered 60 minutes before surgery. A cohort of animals (n = 16 per group) receiving the same protocols were used to assess survival rates. The survival rate was evaluated within 72 hours in each group.
+ Open protocol
+ Expand
6

PPARγ Antagonist Effects on Microglia

Check if the same lab product or an alternative is used in the 5 most similar protocols
All of the experiments were conducted 24 hr after the cells were seeded. Primary microglial cells were respectively treated with the PPARγ antagonist rosiglitazone (Selleck Chemicals, Houston, TX, USA) or the PPARγ antagonist T0070907 (Selleck Chemicals) diluted in dimethylsulfoxide (DMSO; Sigma) with a final concentration of 0.1 μm, which was applied after the treatment with LPS (0.01 μg/ml; Sigma‐Aldrich, St. Louis, MO, USA). The BV2 cells were passaged before reaching confluence using 0.025% (v/v) trypsin/EDTA in PBS, and they were seeded on poly‐D‐lysine‐coated dishes at a suitable density. Then, 10 μg/ml LPS was applied to differentiated BV2 cells 15 min before the treatment with 10 μm PPARγ antagonist T0070907, and they were then cultured in a humidified 5% CO2–95% air environment at 37°C for 24 hr. Radicicol (0.025 μm and 0.05 μm; Selleck Chemicals) and 3‐MA (500 μm; Sigma‐Aldrich) were used as the LKB1 inhibitor and autophagy inhibitor, respectively.
+ Open protocol
+ Expand
7

Chondrocyte Extracellular Matrix Regulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
In the preliminary experiments, we explored the effects of different concentrations of PPARγ inhibitor (T0070907, Selleckchem, USA) on extracellular matrix proteins in chondrocytes. Finally, 12.5 µM T0070907 was selected for use in subsequent experiments. The chondrocytes were seeded in six-well plates (2 × 106 cells/well) and treated as follows: 1) Control group - 0.1% DMSO; 2) PPARγ inhibitor group - treated with 12.5 µM T0070907 for 48 hours at 37°C; 3) PPARγ inhibitor+ UTMDSV group - treated with 12.5 µM T0070907 and 1 µM simvastatin-loaded microbubbles under US (1 MHz, 0.3 W/cm2) for 30 seconds, and continued cultivation for 48 hours at 37°C; 4) UTMDSV group-treated with 1 µM simvastatin-loaded microbubbles under US (1 MHz, 0.3 W/cm2) for 30 seconds and continued cultivation for 48 hours at 37°C.
+ Open protocol
+ Expand
8

Ginsenoside Rf Modulates Estrogen Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Ginsenoside Rf was supplied by the Korea Ginseng Cooperation (Daejeon, Korea). 17-β-estradiol, dihydrotestosterone, and bicalutamide were purchased from Sigma (St. Louis, MO, USA). T0070907 was purchased from Selleckchem (Houston, TX, USA). ICI 182,780 (ICI) was purchased from ZENECA pharmaceutical (Tocris, UK). Fetal bovine serum and penicillin/streptomycin were purchased from GIBCO Invitrogen (Grand Island, NY, USA). Cell counting kit-8 (CCK-8) was bought from ENZO (Enzo LifeSciences, Lausen, Switzerland). Anti-COX-2 was used from Cayman Chemical (160106), anti-β-actin was used from Sigma (A5441). Anti-sirtuin-1 (SIRT-1), anti-PPARγ, and anti-peroxisome proliferator–activated receptor gamma coactivator-1 alpha were used from Santa Cruz Biotechnology (sc-15404, SC-7196, SC-13067).
+ Open protocol
+ Expand
9

Investigating PPARγ, TLR4, and TGF-β Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
T0070907 was purchased from Selleck Chemicals (Houston, TX, USA). Anti-peroxisome proliferator-activated receptor γ (PPARγ), anti-Toll-like receptor (TLR) 4, anti-transforming growth factor (TGF)-β, and anti-β-actin were obtained from Abcam (Cambridge, Cambs, UK). ELISA kits of transforming growth factor (TGF)-β1, IL-1β, and IL-6 were purchased from Ray Biotech, Inc. (Atlanta, GA, USA). Malondialdehyde (MDA) and superoxide dismutase (SOD) detection kits were purchased from Jiancheng Bioengineering Institute of Nanjing (Nanjing, JS, CHN).
+ Open protocol
+ Expand
10

Antibody-based Protein Signaling Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primary antibodies detecting PPARγ, Phosphatase and tensin homolog (PTEN), phospho-Akt (Ser473), p21 Waf1/Cip1, phospho-Bad (Ser136), Phospho-FoxO1 (Ser256), Phospho-Bcl2 (Ser70), and HRP-labeled secondary antibodies were purchased from Cell Signaling Technology (MA, USA). Antibodies detecting phospho-Akt (Ser473) and PPARγ in the immunohistochemistry were purchased from LifeSpan (Seattle, WA, USA). The PPARγagonists rosiglitazone and pioglitazone, the inverse-agonist T0070907, and the antagonist GW9662 were purchased from Selleck Chemicals (TX, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!